Discover International’s Post

𝗢𝗿𝗴𝗮𝗻-𝗼𝗻-𝗮-𝗖𝗵𝗶𝗽 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟬. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 The report offers a comprehensive overview of the Organ-on-a-Chip industry chain, encompassing the market status of Pharmaceutical & Biotechnology Companies (Brain-on-a-chip, Liver-on-a-chip) and Academic & Research Institutes (Brain-on-a-chip, Liver-on-a-chip). It examines key enterprises in both developed and developing markets, analyzing cutting-edge technology, patents, applications, and market trends of Organ-on-a-Chip. Regional analysis highlights steady growth in North America and Europe, driven by government initiatives and heightened consumer awareness. Meanwhile, Asia-Pacific, particularly China, leads the global market due to robust domestic demand, supportive policies, and a strong manufacturing base. The report provides a holistic understanding of the Organ-on-a-Chip market, delving into market dynamics, trends, challenges, and opportunities within the industry. 𝗧𝗼 𝗞𝗻𝗼𝘄 𝗗𝗲𝗺𝗮𝗻𝗱 𝗼𝗳 𝗢𝗿𝗴𝗮𝗻-𝗼𝗻-𝗮-𝗖𝗵𝗶𝗽 𝗠𝗮𝗿𝗸𝗲𝘁. 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/dQhvXkDt *𝗕𝘆 𝗧𝘆𝗽𝗲: Brain-on-a-chip, Liver-on-a-chip, Kidney-on-a-chip, Lung-on-a-chip, Heart-on-a-chip, Intestine-on-a-chip, Vessel-on-a-chip, Other Organs *𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Cosmetics Industry, Others *𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa *𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: Emulate, Inc., MIMETAS, TissUse GmbH, Valo Health, CN Bio , Hesperos Inc., Micronit, Kirkstall Ltd, Cherry Biotech , Altis Biosystems, NETRI, Xona Microfluidics, SynVivo, Inc #OrganOnAChip #Biotechnology #Pharmaceuticals #ResearchInstitutes #MedicalTechnology #Innovation #HealthcareTech #MarketAnalysis #TechnologyTrends #Bioengineering #OrganoidTechnology #HealthTech #BiomedicalResearch #LifeSciences #Microfluidics #TissueEngineering #RegenerativeMedicine #DrugDevelopment #HealthcareInnovation #Biochips #MarketResearch

🌟 Exciting News in Biotechnology! 🌟 In the ever-evolving world of biotech, groundbreaking innovations are taking center stage. Discover the latest advancements in the field that are reshaping the future of healthcare and beyond. Read the full article here: https://lnkd.in/ezEvc8JP #Biotechnology #Innovation #Healthcare #BusinessTodayNews

📢 Hey there, engineering enthusiasts! Ever wondered about the future of biotechnology coming from the land of the rising sun? 🌅 Look no further! Our latest blog post is all about that! 🔗 https://lnkd.in/e8bHK3Jx We dive deep into most of the innovation happening right now by taking closer looks at some of the emerging Japanese biotech engineering companies pushing the boundaries in their respective fields. 🧪 Featuring: Rena Therapeutics Inc. / レナセラピューティクス株式会社: Founded by Junichi Yano, a trailblazer in the pharmaceutical market, specializing in the development of nucleic acid drugs. Rhelixa: Pioneered by Ryu Nakagi, Rhelixa is at the forefront of genome, epigenome, and transcriptome analysis, driving innovation in genetic research. Langualess: Innovating in the field of communication, Langualess, established by Joji Yamaguchi, utilizes a novel heart rate analysis method to revolutionize interactions. Noile Immune Biotech: A venture from Yamaguchi University, Noile-Immune Biotech, founded by Hidenobu Ishizaki, focuses on developing cutting-edge cancer immunotherapies. CellFiber Co., Ltd.: Co-founded by Okitsu Teru & Shoji Takeuchi, CellFiber Co., Ltd. is redefining the landscape of cell culture technology, particularly for cell and gene therapy applications. Femto Deployments: Founded by Watanabe Akira, Femto Deployments enhances business processes in the liquid domain, offering innovative solutions. Adipo Medical Technology, under the leadership of Hachiro Senoo, excels in the pharmaceutical sector, specializing in regenerative medicine products. FRONTEO Healthcare is making significant strides in improving healthcare services through advanced biotechnology applications. Kisvin Science Inc. uniquely blends agriculture with biotechnology and the internet of things, creating a new realm of agricultural tech. Edit Force: Led by Takahiro Nakamura, the vanguard of biotechnology, focusing on the development of drugs and seeds through nucleic acid manipulation technologies. Robotic Biology Institute Inc. combines bioinformatics and biotechnology, forging a new path in biological research and development. This post encapsulates the Japanese biotech engineering industry's dynamic and innovative spirit, featuring companies pushing the boundaries in their respective fields. Join the conversation about these exciting advances in biotechnology happening in Japan right now! #biotech #tech #innovation #engineering #bioengineering

𝗔𝗽𝘁𝗮𝗺𝗲𝗿𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟭. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 The research report provides an overview of the Aptamers industry chain, focusing on the market status of DNA-Based Aptamers and RNA-Based Aptamers in Research and Development and Drug Discovery applications. It examines key enterprises in both developed and developing markets, analyzing the latest technology advancements, patents, and emerging applications within the Aptamers sector. Regionally, North America and Europe demonstrate stable growth, supported by government initiatives and increasing consumer awareness, while Asia-Pacific, particularly China, emerges as the global leader in the Aptamers market, benefiting from robust domestic demand, supportive policies, and a well-established manufacturing base. The Aptamers market is segmented by Type and Application, providing precise forecasts for consumption value by Type and Application from 2024 to 2031 in terms of volume and value, aiding businesses in strategic decision-making and market expansion efforts. 𝗧𝗼 𝗞𝗻𝗼𝘄 𝗚𝗹𝗼𝗯𝗮𝗹 𝗦𝗰𝗼𝗽𝗲 𝗮𝗻𝗱 𝗗𝗲𝗺𝗮𝗻𝗱 𝗼𝗳 𝗔𝗽𝘁𝗮𝗺𝗲𝗿𝘀 𝗠𝗮𝗿𝗸𝗲𝘁. 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/eyMWsJpF *𝗕𝘆 𝗧𝘆𝗽𝗲: DNA-Based Aptamers, RNA-Based Aptamers *𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: Research and Development, Drug Discovery *𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa *𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: TriLink BioTechnologies, part of Maravai LifeSciences, SomaLogic, Aptamer Sciences Inc., Base Pair Biotechnologies, Inc., Aptamer Group, Aptagen, LLC, Aptus Biotech, NeoVentures Biotechnology Europe, RayBiotech, Vivonics, Inc. #aptamers #biotechnology #molecularbiology #research #biomedical #biotech #science #molecularrecognition #drugdiscovery #diagnostics #therapeutics #biomolecules #nanotechnology #molecularengineering #pharmacology #biomarkerdiscovery #targetedtherapy #biomedicalresearch #molecularmedicine #aptamerdevelopment #biomolecularengineering #biosensors #biomedicalengineering #nanomedicine #precisionmedicine #clinicalresearch #biomolecularinteractions #aptamertechnology #medicalresearch #innovation

I’m thrilled to announce that Lactocore Group is actively seeking a seed investment round for our innovative Reptide platform, which is set to revolutionize the field of biotechnology with AI-enhanced peptide drugs. Regulatory peptides are not just the most abundant class of signaling molecules in our bodies; they are also among the most successful types of drugs on the market today. At Lactocore, we are pushing the boundaries of this success further by harnessing cutting-edge solutions in structural bioinformatics and artificial intelligence. Our proprietary technology — comprising a proprietary dataset and spiking neural network architecture — enables us to explore new chemical spaces for proven pharmaceutical targets. We have developed a robust pipeline of peptide drug candidates tailored for psychiatric and metabolic disorders. Our leading program, aimed at treating anxiety, is prepared for IND/CTA-enabling studies. In addition, we are advancing promising assets in neurological disorders, diabetes, and cardiovascular diseases. This seed round represents a remarkable opportunity for early-stage investors to join us on a transformational journey in the pharmaceutical industry. We are looking for partners who share our vision and commitment to innovate and deliver groundbreaking treatments that can significantly improve patient outcomes. Interested in learning more about how you can participate in our growth story? Please reach out directly to discuss how we might collaborate on this exciting venture. #Biotechnology #StartUpInvesting #HealthTech #AI #Pharmaceuticals #InvestmentOpportunity #MentalHealthAwareness #Innovation #LifeSciences #PeptideTherapy

Do you imagine a future where proteins themselves can be manipulated to actively fight diseases? Photys Therapeutics, is bringing us one step closer to that reality. Their proprietary bifunctional small molecules platform aims to restore protein function, repair signaling, and amplify endogenous disease-fighting mechanisms, marking a significant revolution in biotechnology. Working in collaboration with Broad Institute and backed by scientific allies such as MIT’s Angela Koehler, Salk’s Tony Hunter, Berkeley’s Dan Nomura, MPM’s Wendy Young, and Dana Farber’s Eric Fischer, Photys is pushing boundaries to unlock fine-tuned control of protein modifications. Dive deep into their ground-breaking work in our latest article: https://lnkd.in/e8iWiHUt Join the discussion and tell us your thoughts about this innovative journey that's redefining biotechnology! #PhotysTherapeutics #Biotechnology #ProteinFunction #HealthTech #Innovation #Startups #USVentureNews.

𝐁𝐢𝐨𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐫𝐞𝐚𝐠𝐞𝐧𝐭𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐖𝐢𝐭𝐧𝐞𝐬𝐬 𝐌𝐚𝐬𝐬𝐢𝐯𝐞 𝐆𝐫𝐨𝐰𝐭𝐡, 𝐄𝐦𝐞𝐫𝐠𝐢𝐧𝐠 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝐛𝐲 𝟐𝟎𝟐𝟒-𝟐𝟎𝟑𝟎   Biotechnology reagents market size was estimated at 𝐔𝐒𝐃 𝟓𝟗𝟓.𝟑 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 in 2024 and is anticipated to grow at a compound annual growth rate (𝐂𝐀𝐆𝐑) 𝐨𝐟 𝟏𝟎.𝟗% from 2024 to 2030 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐮𝐥𝐥 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/eQWcHsc9 𝐁𝐢𝐨𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐑𝐞𝐚𝐠𝐞𝐧𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰 Biotechnology Reagents #Market is a #dynamic and rapidly growing sector, driven by significant advancements in life sciences and medical research. The market includes a variety of reagents used in numerous applications such as #DNA and #RNA analysis, protein #purification, drug testing, and gene expression studies. These reagents are essential for processes in molecular biology, genomics, proteomics, and clinical #diagnostics. 𝐖𝐡𝐢𝐜𝐡 𝐢𝐬 𝐭𝐡𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐊𝐞𝐲 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐨𝐟 𝐁𝐢𝐨𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐑𝐞𝐚𝐠𝐞𝐧𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭?  𝟏. 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬 𝐢𝐧 𝐆𝐞𝐧𝐨𝐦𝐢𝐜 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡: Technologies such as next-generation sequencing (NGS) and #CRISPR have revolutionized genomic studies, increasing the #demand for reagents used in these processes. 𝟐. 𝐏𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐳𝐞𝐝 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞: Shift towards personalized medicine, which tailors treatments based on individual genetic profiles, is a #significant driver for the #biotechnology reagents market. 𝟑. 𝐑&𝐃 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭𝐬: Substantial investments in biotechnological research and development by both government and private sectors are bolstering market #growth. 𝟒. 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧𝐬: Continuous innovations in biotechnology, including improvements in #PCR techniques, flow cytometry, and #chromatography, are enhancing the #efficiency and application range of biotechnology reagents. 𝐓𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐩𝐫𝐨𝐯𝐢𝐝𝐞𝐬 𝐝𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐩𝐫𝐨𝐟𝐢𝐥𝐞 𝐚𝐧𝐝 𝐝𝐚𝐭𝐚 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐨𝐟 𝐥𝐞𝐚𝐝𝐢𝐧𝐠 𝐜𝐨𝐦𝐩𝐚𝐧𝐲 Beckman Coulter Life Sciences GE HealthCare bioMérieux Hoefer Welker Merck Life Science BD Sigma AI Lonza PERKINELMER (INDIA) PrivateLimited. Quality Digital 𝐈𝐟 𝐲𝐨𝐮 𝐡𝐚𝐯𝐞 𝐚𝐧𝐲 𝐄𝐧𝐪𝐮𝐢𝐫𝐲 𝐩𝐥𝐞𝐚𝐬𝐞 𝐜𝐥𝐢𝐜𝐤 𝐡𝐞𝐫𝐞 https://lnkd.in/eCx2cRYK Ample Market Research & Consulting Private Limited Business News Watch #BiotechnologyReagents #BiotechMarket #Genomics #DNAAnalysis #PCR #ProteinPurification #DrugTesting #GeneExpression #LifeSciences #ResearchAndDevelopment #BiotechInnovation #MolecularBiology #ClinicalDiagnostics #BiotechIndustry #LabReagents

Hello Connections !!! Recently I attended the Popular Lecture Seminar and Scientific Session on "BIOTECHNOLOGY PROSPECTIVE IN HEALTHCARE AND NUTRACEUTICALS" highlights the event's focus on the potential of biotechnology to revolutionize the healthcare and nutraceutical industries. The seminar held and organized by Department of Biotechnology (DBT) (Govt. of India, New Delhi) Sponsored & Sanjivani College of Pharmaceutical Education and Research Kopargaon, India, on 24th February 2024, featured experts discussing the latest advancements and trends in biotechnology applications for healthcare and nutraceuticals. Key topics included personalized medicine, gene editing technologies, bioinformatics, and bioprocessing techniques for nutraceutical production. The seminar emphasized the role of biotechnology in developing innovative therapies, enhancing nutraceutical products, and improving overall health outcomes. Attendees gained valuable insights into the transformative power of biotechnology in these sectors and were inspired to drive innovation and growth in the field. #pharma #pharmacyeducation #biotechnology #nutraceutical

#SaudiArabia ’s biotechnology and genomics #sector is likely to record double-digit growth as it #plans to #invest 2.5 percent of its gross domestic #product in #research and #development by 2040, aiming to add $16 #billion to its #economy.